Under the revised Common Rule, the IRB is permitted to release a study from continuing review if it is determined to be minimal risk and reviewed through an expedited mechanism. Study teams are still required to submit modifications, reportable new information, and a study closure.
In order to keep PittPRO up to date, a reminder will be sent close to the anniversary of IRB approval. Upon receipt of the reminder, action may or may not be required:
- No action is required on your part if the study remains ongoing.
- A continuing review should be submitted to close out the study if it is completed.
Please contact us at email@example.com with any questions.